2005
DOI: 10.1128/jvi.79.2.1062-1070.2005
|View full text |Cite
|
Sign up to set email alerts
|

Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine

Abstract: Sabin strains used in the manufacture of oral polio vaccine (OPV) replicate in the human organism and can give rise to vaccine-derived polioviruses. The increased neurovirulence of vaccine derivatives has been known since the beginning of OPV use, but their ability to establish circulation in communities has been recognized only recently during the latest stages of the polio eradication campaign. This important observation called for studies of their emergence and evolution as well as extensive surveillance to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
35
0
2

Year Published

2006
2006
2010
2010

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 49 publications
(38 citation statements)
references
References 34 publications
1
35
0
2
Order By: Relevance
“…1). Three slightly diverged isolates of type 2 (PV2/3d, PV2/60d, and PV2/ 78d) from a paralytic case in an immunodeficient child as well as two highly diverged OPV derivatives (type 1 strain 14 and type 3 strain 11264) isolated from a VAPP case and contact person, respectively, have been described in detail elsewhere (10)(11)(12). For clarity, type 1 strain 14 and type 3 strain 11264 will be named henceforth VDPV-1 and VDPV-3, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…1). Three slightly diverged isolates of type 2 (PV2/3d, PV2/60d, and PV2/ 78d) from a paralytic case in an immunodeficient child as well as two highly diverged OPV derivatives (type 1 strain 14 and type 3 strain 11264) isolated from a VAPP case and contact person, respectively, have been described in detail elsewhere (10)(11)(12). For clarity, type 1 strain 14 and type 3 strain 11264 will be named henceforth VDPV-1 and VDPV-3, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…The rates appear to be similar across the three poliovirus serotypes and for both circulating polioviruses and polioviruses associated with chronic infections. This very rapid rate of genomic evolution has facilitated high-resolution molecular epidemiologic studies, permitting the unambiguous identification of the sources of imported viruses (10, 41) and the resolution of separate lineages during outbreaks (39,43,74,75), during endemic transmission (23,52,90), during prolonged poliovirus replication in immunodeficient patients (9,31,53,89), and from environmental surveillance (23). However, the rapid accumulation of nucleotide substitutions, most of which are synonymous transitions, obscures deeper evolutionary relationships (46,70).…”
mentioning
confidence: 99%
“…1), a feature which appears to be not infrequent among VDPV and which poses problems for precise evaluation of the viral "age." In some cases, such unevenness could be explained by intratypic recombination (8,28). This explanation seems to be especially realistic for PV2/Rus, whose history involved multiple recombination events apparently occurring between partners of different "ages."…”
Section: Vol 83 2009mentioning
confidence: 99%
“…Uncertainties of the causes of uneven accumulation of synonymous mutations notwithstanding, the extent of this accumulation in the VP1-coding region is widely used and has proved to be a relatively reliable measure of the VDPV "age." Assuming the rate of 3 ϫ 10 Ϫ2 synonymous substitutions per synonymous site per year (8), PV2/Bel and PV2/Rus were estimated to be ϳ1.6 and ϳ1.2 years "old," respectively. If PV2/Bel iVDPV could likely have replicated only within a single immunodeficient host, PV2/Rus, being isolated from a 6-month-old unvaccinated baby, had certainly passed through more than one person.…”
Section: Vol 83 2009mentioning
confidence: 99%